Patients with health conditions want to learn about their medication options: We explore how pharma brands and marketers can better position themselves as patient educators.
Uber steers into the caregiver space: Uber’s newest feature could help patients and insurers alike. But there are a few factors that could prevent Uber Caregiver from reaching its full potential.
Healthcare leaders applaud Ascension’s cyberattack response: A healthcare organization’s reaction to a cyberattack can make all the difference when it comes to reputation.
GoodRx inks direct contracting agreement with Kroger: Investors should be happy with GoodRx’s redefined approach to drug pricing and pharma partnerships.
LG bets on home healthcare: But the company may struggle to capture market share from entrenched home health rivals like Best Buy Health and Samsung.
Transcarent to release healthcare AI chatbot: We unpack the utility the GPT-4-powered tool could hold for patients and give our take on why the lauded chat-based virtual care revolution is overblown.
Ogilvy launches influencer marketing offering for health brands: We explore the value that agencies can bring to healthcare and pharma brands looking to forge tie-ups with social health influencers.
Some hospitals refuse surgeries without upfront payments: We explore the broader implications this could have on health equity.
Pharma advertisers are pushing into CTV: They’re evolving with consumers’ ever-changing media consumption trends.
Kraft Heinz weighs Oscar Mayer sale amid mounting criticism of processed foods: The company is on a multi-year path to make its products more nutritious in response to shifting consumer preferences.
Patients frequently go out of network for mental healthcare vs. medical care: The No. 1 factor driving this discrepancy? Lack of coverage options. The Biden administration is calling on insurers to change that, though.
New DOJ task force investigates anticompetitive behavior in healthcare: The feds want to rein in vertical integration in healthcare. UnitedHealth Group will likely be under the spotlight first.
Positive experiences are the key to retaining patients: We dive into new study results showing why US consumers switch providers and insurers and unpack what both need to do to stop customers from jumping ship.
US Rx spending outlook through 2028: We look back at medication use and spending in 2023 while exploring what will drive spending growth through 2028.
Vitamin Shoppe launches GLP-1 telehealth service: Another legacy retailer is throwing its hat in the GLP-1 ring. Here’s why the promise of low cost GLP-1s isn’t always what it seems.
Talkspace enters first quarter of profitability: We explore why moving deeper into the health plan market is a smart business move.
Hims & Hers’ stock price flips after topsy-turvy week: CEO Andrew Dudum’s controversial comments on Gaza came days before the company’s record-level subscriber growth. Is this a lesson learned for brands and marketers?
Ro’s new approach to integrated virtual care: Market factors like low telehealth usage are driving some virtual care players to differentiate, and others out of the market entirely.
FDA OKs Apple Watch’s aFib history for clinical studies: The Watch becomes the first digital health tool to be qualified under the FDA’s Medical Device Development Tools program. Here’s what it means for Apple’s health ambitions.
Patients’ health journeys begin online: Here’s what healthcare and pharma marketers need to know about how online-acquired information influences patient action.